The goal of this work is to review the principles, design, and function of the ISS multilateral medical authority and the medical support system of the ISS Program. Multilateral boards and panels provide operational framework, direct, and supervise the ISS joint medical operational activities. The Integrated Medical Group (IMG) provides front-line medical support of the crews. Results of ongoing activities are reviewed weekly by physician managers. A broader status review is conducted monthly to project the state of crew health and medical support for the following month. All boards, panels, and groups function effectively and without interruptions. Consensus prevails as the primary nature of decisions made by all ISS medical groups, including the ISS medical certification board. The sustained efforts of all partners have resulted in favorable medical outcomes of the initial fourteen long-duration expeditions. The medical support system appears to be mature and ready for further expansion of the roles of all Partners, and for the anticipated increase in the size of ISS crews.
Introduction
The current stage of human spaceflight is characterized by unprecedented technological advancements and broad international cooperation in the assembly and operation of the International Space Station (ISS). Medical support is among the areas where synergistic inputs from all Partners (Russian Federal Space Agency (FSA), the U.S. National Aeronautics and Space Administration (NASA), the European Space Agency (ESA), the Canadian Space Agency (CSA), and the Japan Aerospace Exploration Agency (JAXA)) have resulted in a robust and highly effective multilateral system.
Up to the mid-1990s, the medical support systems for human space flight in Russia and the U.S. differed substantially. However, the founding documents of the ISS Program called for integration of medical support through integrated crews, a common system of medical support, and coordination of crew health matters on the principle of consensus. [1, 2] Efforts and resources of all Partners were to be coordinated for the development and operation of a joint system that would best maintain health and performance of international crews in all phases of ISS missions. In order to overcome the differences and integrate the national systems of medical support, a number of objectives were identified, first during the phase of preparation and implementation of the U.S.-Russian Shuttle-Mir and NASA-Mir projects [3, 4, 5] , and later within the framework of multilateral cooperation for ISS. These objectives included reduction and mitigation of risks associated with space flight factors that were distinct in their nature, as well as establishment of environmental conditions in habitable compartments of the spacecraft that were conducive to healthy and productive life and work. It was particularly important to provide readily available, effective means and methods of inflight countermeasures to mitigate the well-known adverse effects of long-duration space flight on crew health [6] [7] [8] . Water, food products, air, and the station interior had to be verifiably clean, healthy, and free of toxic impurities and microbiological contamination. Risks had to be predicted and analyzed for nominal flight conditions (launch, dynamic on-orbit operations, EVA, implementation of complex flight programs, and crew return), as well as for the occurrence of various off-nominal situations such as malfunctions of station engineering systems including life support, and failures of medical and exercise equipment. An acceptable crew work/rest schedule had to be worked out, balancing work, exercise, personal time, and sleep, since crew fatigue is known to be a leading cause of performance decrements and operator errors [9] [10] . Finally, the station was to be equipped to identify and treat predictable medical situations on orbit, and to provide means for safe medical evacuation in case of life-threatening emergencies.
Thus, notwithstanding the experience accumulated in all pre-ISS programs and broadly available through many review publications, creation of a common, consensus-based system for medical support of joint crews posed a substantial challenge. Utmost regard and respectful consideration was given by each partner for the knowledge and experience of the others, as well as to their established regulations and procedures for crew medical support. Many large and small 13309.doc obstacles were encountered and overcome to achieve integration and standardization. The cumulative effect of the many previous years of international cooperation in space biology and medicine, along with the leadership of the space medicine managers and experts of all Partners, created favorable conditions for continued cooperation and integration. A number of developments were highly contributory to the development of an effective ISS crew medical support system: interaction and joint operations by NASA and FSA medical communities in the Phase 1 program [4, 5] ; the establishment and operation of the ISS medical boards, panels and working groups; the development of the common ISS medical requirements; adoption of common ISS medical selection standards and evaluation requirements; the joint certification of the first four ISS expedition crews; exchanges of personnel including flight surgeons, and the adoption of the concepts of the Integrated Medical System (IMedS) onboard and the Integrated Medical Group (IMG) on the ground. The joint efforts of all the Partner medical organizations resulted in an effective international system of operational medical support.
Main documents regulating international cooperation on the ISS
The cooperation in construction and operation of the ISS was initiated and authorized by the Agreement Among the Government of Canada, Governments of the Member States of the European Space Agency, the Government of Japan, the Government of the Russian Federation, and the
Government of the United States of America Concerning Cooperation on the Civil International
Space Station, signed in January of 1998 (the Intergovernmental Agreement, or IGA) [1] . The IGA recalls all international space treaties that led to the ultimate development of an international partnership to build and operate the ISS. It recognizes the Russian Federation's "unique experience and accomplishments in the area of human space flight and long-duration missions, including the successful long-term operation of the Russian Mir Space Station." The IGA further stipulates that the United States has the leading role for overall ISS management and coordination, and that detailed provisions for implementation of the agreement would be developed in Memoranda of Understanding (MOU). These MOUs were subsequently developed and signed as bilateral agreements between NASA and each ISS partner, i.e. the Russian Space Agency, the European Space Agency, the Canadian Space Agency, and the Government of Japan.
The basic principles governing the ISS crew health matters are defined in Article 11.4 of each ISS MOUs [2] (Appendix). This Article authorizes three multilateral forums of medical authority, namely the Multilateral Medical Policy Board (MMPB), the Multilateral Space Medicine Board (MSMB), and the Multilateral Medical Operations Panel (MMOP), and provides a framework for 13309.doc consensus-building based on discussion and negotiation, which proved to be viable over time.
Conflict resolution mechanisms built into the IGA and MOU's to assure decision-making capacity of the multilateral groups. However, decisions of medical nature, such as those on space flight medical eligibility of particular individuals, were to remain the prerogative of medical specialists.
ISS Multilateral Medical Authority Structure and Medical Policy Framework
As noted above, the Article 11.4 of the ISS MOUs establishes a multilateral medical authority structure and calls for a joint system of medical support. The entire ISS medical organization is designed on the premise of full cooperation and active participation of all partner members. The MMPB, the MSMB, and the MMOP are the original groups expected to further develop and implement policies, standards, requirements, and operational mechanisms in the framework of the ISS partnership. Groups and forums were thus established to create a system of operational medical services for the ISS. Charters of the three multilateral groups became the initial vehicle to implement the guidance of the MOUs. A considerable effort was applied by all Partners to define roles, responsibilities, and primary functional features of these groups. Considerations were addressed regarding the sensitive nature of the medical authority and the need for decision-making capacity based primarily on medical and safety considerations, without undue bias or influence. The ISS medical authority structure is depicted in Figure 1 .
The Multilateral Medical Policy Board (MMPB) and ISS Medical Policy
The MMPB is the highest level of medical authority responsible for medical policy formulation and oversight of all crew health-related matters. While members of the MMPB are answerable to their respective agencies, the Board as a whole exercises its authority independently of the ISS management bodies and operates on the basis of coordinated decisions (consensus). The NASA and FSA members of the MMPB co-chair the Board until the ISS assembly is completed. MMPB issues medical policy decisions through special Policy Directives, statements in meeting Minutes, letters, and review of high-level ISS documents, such as charters, sets of standards, and requirements. A most prominent feature of MMPB has been its adherence to the fundamental principles discussed below.
Integrated approach to medical policy:
With a goal to ensure the best possible health outcomes for the ISS crew, the MMPB explicitly pronounced an integrated approach to medical policy, requiring and upholding an integrated health support system operating on the best available evidence, with the best available resources and highest ethical standards, as a component "essential to the success of the ISS". In operational situations where the capability of one or more ISS health support systems is degraded, the combined resources of all Partners' components are considered in determining the ability of the remaining ISS systems to support the health and safety of the ISS crew. To facilitate 13309.doc this process, a commitment has been made and followed to share all necessary information among Partners in a timely fashion. Furthermore, consistent with the humanitarian principles of medical care, the ISS Program has expressed determination to make any on-orbit medical capability available to all crewmembers as appropriate, and to cooperate in the analysis of samples and data. Nonemergent medical situations with potential major operational impacts, such as situations requiring medical evacuation, are to be reported to the highest-level medical authority (MMPB) for review.
However, in the event of a medical or health-threatening emergency onboard the ISS, in which there is insufficient time for consultations, the Crew Surgeon at the controlling MCC has the authority to choose the medical response and directly communicate the appropriate recommendations to the ISS Increment Flight Director.
Consensus and Issue
Resolution. The ISS medical policy requires every effort to achieve consensus in medical and health decisions to best support the health of the crew. With the principle of consensus in foremost consideration, and in keeping with NASA's responsibility for overall Space Station management and safety, a detailed process for dispute resolution was adopted, but has never been invoked to the present time. Generally, all Partner medical organizations are determined to achieving final and satisfactory conflict resolution and avoiding referral of medical decisions to non-medical management authorities.
ISS Medical Requirements and Standards
The development and implementation of written medical requirements based on the ISS IGA and MOUs is a complex, multi-dimensional process. During this process consideration is given to space and terrestrial medical knowledge and evidence, medical risk estimates, accepted standards of care in the Partner countries, engineering and planning considerations, as well as crew expectations and concerns. In light of these complexities, there has been an ongoing dialog between the medical community and the Program management to define the medical requirements for long duration space Working Groups perform a detailed analysis and discussion of issues and provide recommendations to the MMOP, thus playing a key role in introducing special partner approaches to the multilateral medical organization.
The Multilateral Space Medicine Board (MSMB) and Crew Medical Certification

The Multilateral Medical Operations Panel (MMOP) and ISS Medical Operations
The Approach to ISS Medical Status Review and Prognostic Evaluation
The system of continuous mission status review and prognostic evaluation is an important feature of the ISS medical support. The ISS Program's medical organization has created an process of health-related information review that routinely combines recent data and anticipatory considerations on a daily, weekly, monthly, and per-increment basis (Fig. 3) . The system maintains a firm grip on all the factors that allow timely identification and mitigation of medical and health risks.
For every given moment, the medical status of the station and its crew has been previously addressed in a "forward-looking" fashion by the previous expedition readiness review, a previous monthly "look-ahead" review, the preceding week's SMOT teleconference, and the daily interactions within the Integrated Medical Group (IMG). This continuous proactive process hinges on multilateral participation.
Daily activities and status review (IMG)
Depending on the mission schedule, various medical operations activities may be scheduled for a given day, such as medical and psychological conferences with the crew, medical testing, or IMedS The daily data are thoroughly documented and a daily status report is completed by the missionassigned biomedical engineers. The medical operations plans are coordinated with the ISS mission planning community and the engineering community if necessary. The Crew Surgeon or Deputy Crew Surgeon is available at all times for immediate communication with mission management, the crew, any mission support personnel, or the medical management of any Partner. The ISS medical organization thus maintains, through the IMG, a current knowledge of the status of the crew health and activities, and is prepared for the activities of the following days.
Weekly status review: Space Medicine Operations Team (SMOT)
Since Protocol is documented and archived in a secure fashion, a "de-privatized" version, stripped of confidential data, is available to any working-level medical operations personnel to ensure the currency of their knowledge of the medically relevant circumstances of the mission.
The SMOT, by the virtue of its unrestricted access to any and all information related to crew health on the one hand, and the authority of the medical managers present, on the other, is seen as the main pathway for short-term operational input into the ISS mission management through the ISS Mission Management Team. Such inputs can be made through a delegate to the MMT meeting, by special written communication on behalf of SMOT, or through the official SMOT protocol (with private data omitted), reflecting the concerns and recommendations. By May of 2006, SMOT had conducted over 330 weekly teleconferences.
Monthly status review: Anticipatory (look-ahead) Medical Operations Status
Reviews
Beginning with ISS Expedition 9, the partners established a monthly anticipatory (lookahead) routine procedure to address operational situations and conditions for the near-term medical support of the ISS crew. These mandatory monthly reviews are scheduled in conjunction with the SMOT teleconferences. Any foreseeable factors that may disrupt the nominal progress of the mission from the medical perspective, or compromise the quality or adequacy of operational medical support, are brought up and discussed. Generally, they follow an SMOT teleconference and consist of reports that identify special operational demands and circumstances of the following month, and estimate the degree of readiness of the IMedS and IMG to meet such demands. Examples have included predictions regarding exercise equipment life cycle limits, ambient noise concerns, or needs of pharmacy replenishment that would claim increased up-mass allocation. This activity has proven to be highly beneficial, as it mobilizes the medical operational personnel to be proactive and consider a longer-term outlook of all the circumstances surrounding the medical support of ISS mission.
Integrated MMOP Review of Mission Medical Readiness
After completion of agency-level readiness reviews, the MMOP Mission Readiness Review event is conducted (generally matched with the last monthly "look-ahead" review of the previous expedition, or an high-priority aspects of the mission, or special concerns from the medical perspective (Table 1 ). The Launch Readiness Statement is a culmination of the multi-level continuous anticipatory reviews system. The MMOP generates readiness statements for non-crew exchange missions as well, if they have any medical implications such as visiting crew flight to ISS). In similarity with the medical support hardware, the ISS medical kits with medication, medical and dental tools and examination devices, dressings, splints, and other small portable medical items, are the responsibility of the agency of origin but united in the same concept of integrated medical assets. The medical items of all origins are always considered when a medical capability for a given situation is assessed.
The Integrated
The capabilities of the IMedS are remarkably robust when compared with any previous space program. Diagnostic equipment, besides electrophysiology and pulmonary function testing, includes a large number of blood and urine tests. For a medical contingency requiring imaging support, the IMedS can be augmented by a multipurpose ultrasound system available in the ISS Human Research Facility. For the first time in the history of human space flight, diagnostic imaging has become a required capability for medical risk mitigation [11, 12] . 13309.doc Any deterioration in behavioral health and performance, especially at critical operational points in the mission, may have direct impact on the mission's safety and success [13, 14] . Ineffective medical and behavioral support could increase the mission and medical risks due to fatigue, task overload, illness, low morale/motivation, or interpersonal frictions within the crew or between the crew and the ground personnel. Such deterioration may be insidious and may remain unnoticed for a long time, to present itself at a critical, unforgiving point when the demands for accuracy and efficiency are the highest. 
Behavioral aspects of ISS missions
Conclusions
The ISS assembly and operation in the piloted mode has been ongoing for over 6 years, partly delayed due to various setbacks. Currently, Expedition 15 is working aboard the station. The duration of expedition crew stays on orbit has ranged from 129 to 196 days. Throughout all of the ISS expeditions, the medical requirements were essentially met and medical operations were performed in accordance with multilaterally adopted documents, particularly the ISS MORD. The structure 13309.doc established to manage medical operations permitted adequate response to occurring problems, thereby assuring crew health and a level of performance required to perform mission tasks. No serious clinical problems among crewmembers were observed neither aboard the station, nor in broader terms of the mission medical outcomes. ISS life support systems were sufficient and adequate, and intermittent temporary failures of individual equipment did not affect crewmember health.
The environmental conditions on the ISS during all flights have, on the whole, remained satisfactory and in conformance with the regulatory requirements of the ISS MORD. Some concern was elicited by noise levels in certain areas of the station and by the occasional need to suppress The availability of necessary capabilities and equipment to perform basic evaluation and monitoring of health and performance of the crew on the station.
Diagnostic and Treatment Capabilities
The availability of equipment and capabilities to adequately diagnose and treat routine medical and dental problems and to perform cardiopulmonary resuscitation (CPR) and basic life support (BLS) procedures.
The ISS Environment
Water and air quality for permanent human presence, existence of plans and equipment for long-duration monitoring of environmental parameters.
Sustaining Human Health
The availability of capabilities and equipment to implement and monitor operational in-flight measures to maintain the human health and to mitigate undesirable effects of space flight. Adequacy reserves of provisions to assure crew dietary needs.
Specific Areas Needing Attention
Requests to the ISS Program to recognize areas of concern or special importance as high-priority areas for the mission. Example: request for "continued attention of the ISS Program to maintaining the functionality of all exercise countermeasures devices (RED, TVIS, VB-3 with force loaders, CEVIS, BD-1), as to a high-priority Program goal for sustaining crew health and performance throughout the expedition." Summary An MMOP declaration regarding the absence or presence of medical constraints for the mission, per the readiness criteria in the current version of the ISS MORD. Example: "At the time of this review, no medical constraints exist to ISS 11 Expedition and the 10S mission, per the agreed upon readiness requirements of ISS MORD Rev B. The MMOP finds that the crew is fully prepared for this flight and the ISS is safe and operationally ready to support the arrival of the crew and the performance of their mission."
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